◼ Archived
Business
🔮 holds ✗
KRAS
3 independently sourced, verified news trends involving KRAS.
Coverage evidence
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 1 news category, from Jul 2, 2026 through Sep 29, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
◼ Archived
Business
🔮 holds ✗
Revolution Medicines shares promising data around KRAS drug combination
Revolution Medicines has released promising Phase 1/2 clinical data for a KRAS drug combination targeting metastatic pancreatic cancer.
◼ Archived
Business
🔮 holds ✗
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
Roche's drug candidate divarasib outperformed rival therapies in a Phase 3 trial for KRAS-driven lung cancer.